Funding round closure of Fusion Bionic

The German High-Tech startup Fusion Bionic, which empowers technical surfaces using laser-assisted biomimetics, closed its first seed funding with a comfortable seven-digit figure led by Technologiegründerfonds Sachsen (TGFS) and joined by Fraunhofer Technology Transfer Fund (FTTF) and Avantgarde Labs Ventures.

The founders of Fusion Bionic. From left to right: Tim Kunze, Laura Kunze, Sabri Alamri, Benjamin Krupop.  

The Dresden-based company, a spin-off from Fraunhofer Institute for Material and Beam Technology IWS, develops and distributes systems for the fabrication of biomimetic surfaces using patented laser microtexturing technologies. The solutions offered by Fusion Bionic are up to 100 times faster than established methods, thus paving the way for high-performance surfaces across various industries and enabling self-cleaning properties, anti-icing characteristics, reduced friction, improved contact performance and many more. 

“So far, the industrial production of functional surfaces on products is typically achieved using coatings or lithographic processes. However, many technical surfaces demand new ways to improve their performance where traditional coatings are not applicable or are not enough to succeed. On top of that, green manufacturing aspects such as sustainability and ecologic viability are important, which need to be economically attractive at the same time. Our laser-based biomimetic approach provides a completely new degree of freedom in surface design at an unprecedented high-speed allowing for novel products and processes.”, explains Tim Kunze, co-founder and CEO of Fusion Bionic. 

During their time at Fraunhofer, the founders developed both the technical concepts and the functionalities of their approach, bringing the technology to maturity. “Deploying a unique, cutting-edge laser technology is the next generation of fabrication solutions for bringing biomimetic surfaces to the market. We as Technologiegründerfonds Sachsen have gladly led this investment round, supporting Fusion Bionic to leverage the great business potential on an international scale. Our latest financial commitment reflects our belief in the company’s advanced solutions as well as our trust in its highly skilled, experienced, and motivated management team. As part of the vibrant start-up scene in Dresden, Fusion Bionic demonstrates the innovative power of the Saxonian high-tech ecosystem. Our TGFS team is excited to be part of this strong network of nationwide investors, boosting the further growth of Fusion Bionic.”, underlines Martin Liebsch, Investment Manager at TGFS. 

Thong Le Hoang, Investment Manager at FTTF, adds “Fusion Bionic is a great example of how technology enables us to mimic the complex structures of nature and capitalize on their unique functionalities. Their concept of biomimicking can be applied to various industry sectors and, more importantly, at large scale. This opens great opportunities to tackle existing problems and create unprecedented products. We believe that Fusion Bionic is a pioneer in the surface functionalization market and has the potential to disrupt the way we think about surfaces. We are very happy to welcome the team to our portfolio and we are ready to revolutionize the world of surfaces together with them.” 

Founded in early 2021, the company already attracted significant customer interest of multiple industrial partners worldwide. Recently, Fusion Bionic has been selected by Heraeus as part of its Accelerator Program 2021 out of +1800 world-wide active startups. The closed seed investment into Fusion Bionic will fuel for the foundation of an application center for laser-based surface functionalization as well as a prediction platform based on artificial intelligence to speed-up the development of laser functionalities. “Using artificial intelligence together with photonics technology is a key enabler for future innovation and we believe that the vision of Fusion Bionic will set a corner stone in this field.”, adds Torsten Hartmann, Co-Founder and Managing Director at Avantgarde Labs Ventures. 

Kunze shared his long-term vision of Fusion Bionic: “We truly believe that biomimetic surfaces will enable the next generation of products and processes ready to tackle major global challenges such as water supply and energy generation. It is our ambition to shape the future using bionic principles.” 

About Technologiegründerfonds Sachsen (TGFS) 

TGFS is an equity investor for knowledge-based, technology-oriented start-ups in Saxony. It is the leading start-up financier in the Free State and accompanies teams with venture capital and management support in both the seed and start-up phases. An investment by TGFS opens access to further international investors for portfolio companies. 

About Fraunhofer Technology Transfer Fund (FTTF) 

The Fraunhofer Technology Transfer Fund (FTTF) is a financing partner for young high-tech companies of the Fraunhofer-Gesellschaft. As a strong, entrepreneurial partner, FTTF finances Fraunhofer start-ups from the pre-seed phase, and in further financing rounds with additional investments of up to five million euros. The fund also accompanies talented entrepreneurs with extensive start-up experience and a broad investor network to realize the full potential of the companies on the market. 

About Avantgarde Labs Ventures 

Avantgarde Labs Ventures is an early-stage investor for technology-oriented start-ups operating in fast-growing B2B markets. In addition to venture capital investments Avantgarde Labs Ventures offers operational support in real time software systems, data analytics and artificial intelligence. 

About Heraeus 

Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company. The company’s roots go back to a family pharmacy started in 1660. Today, the Heraeus group includes businesses in the environmental, electronics, health, and industrial applications sectors. Customers benefit from innovative technologies and solutions based on broad materials expertise and technological leadership. 
In the 2020 financial year, Heraeus generated revenues of €31.5 billion with approximately 14,800 employees in 40 countries. Heraeus is now one of the top 10 family-owned companies in Germany and holds a leading position in its global markets. 

Leave a Reply

Your email address will not be published. Required fields are marked *